EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis
Status:
Completed
Trial end date:
2017-04-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out whether rivaroxaban is safe to use in children and
how long it stays in the body. Safety will be assessed by looking at the incidence and types
of bleeding events. There will also be a check for worsening of blood clots.